Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

12.48
BATS BZX Real-Time Price
As of 10:14am ET
 +0.23 / +1.88%
Today’s Change
5.53
Today|||52-Week Range
13.84
+10.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues27.8M28.0M33.9M14.8M
 
 
 
 
 
Depreciation And Amortization1.4M570.0K412.0K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income------13.8M
 
 
General Expenses40.4M51.2M38.6M43.8M
 
 
 
 
 
Research And Development33.8M43.6M30.7M35.7M
 
 
 
 
 
Total Operating Expenses41.7M51.7M39.0M44.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.9M-23.7M-5.1M-30.0M
 
 
 
 
 
Interest Expense On Debt4.6M4.6M4.6M4.6M
 
 
 
 
 
Other Expenses161.0K265.0K151.0K113.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.3M-28.0M-9.5M-34.4M
 
 
 
 
 
Minority Interest-181.0K-137.0K-219.0K-327.0K
 
 
 
 
 
Net Income-18.1M-27.9M-9.7M-34.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS103.8M104.9M106.7M107.1M
 
 
 
 
 
Shares To Calculate EPS Diluted103.8M104.9M106.7M107.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.27-$0.09-$0.32
 
 
 
 
 
EPS Diluted-$0.17-$0.27-$0.09-$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account